Accord Logo

Intended for UK patients and members of the public

IMULDOSA® Concentrate for Solution for Infusion

Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. Please click here for more information.

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

IMULDOSA® 130 mg concentrate for solution for infusion (active: ustekinumab)

Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. Please click here for more information.

PL Number:
PLGB 20075/1554
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: